Effects of PDCA method on improving the accuracy of the Autar Deep Venous Thrombosis Scale / 中国实用护理杂志

Objective:To investigate the effects of PDCA method on improving the accuracy of the Autar Deep Venous Thrombosis (DVT) Scale used by nurses to assess the risk of deep venous thrombosis in surgical patients.Methods:Applied the way of PDCA, namely, raising questions, analyzing reasons, implementing measures, feeding back effects to professional explanate the difficulty in using the scale, moreover, training the nurses used level education method between August 2017 and December2018.The accuracy and consistency of the scale were compared before and after interventions.Results:A total 396 patients were evaluated in the study. There were significant differences in the consistency of evaluation among hospitalized, post-operative and discharged patients after intervention compared with before intervention ( P< 0.0167).The consistency of assessment of team members and responsible nurses increased from 68 to 120 cases, and the consistency of assessment reached 90.91%. The Kappa consistency of assessment of responsible nurses and team members increased from 0.354 before intervention to 0.879 after intervention. The effect was remarkable. Conclusions:PDCA cycle method is based on the problems found in clinical practice. It clarifies the professional terms and rules used in the scale, improves the accuracy and consistency of the Autar DVT scale used by nurses, correctly reflects the risk of thrombosis, ensures the safety of patients, and is worthy of promotion and reference.

Pharmacogenetics progress of commonly-used chemotherapeutic drugs for acute leukemia / 白血病·淋巴瘤

Leukemia is a common and harmful disease for humans. Chemotherapy is the main treatment method. During the decades of experience, the clinicians have found that these drugs work well, but obvious individual differences occur in different patients. Some concerns of the clinicians exist such as how to learn more about the factors that may induce drug resistance and adverse reactions, and how to improve the efficacy of chemotherapy drugs, reduce drug resistance and side effects. This paper reviews the effect of genetic factors of commonly-used chemotherapeutic drugs for acute leukemia, aiming to provide a theoretical foundation for personalized administration of these chemotherapeutic drugs.